KurtzkeJF.Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
2.
PolmanCHReingoldSCBanwellB. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2011; 69: 292–302.
3.
LublinFDReingoldSCCohenJA. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology2014; 83: 278–286.
4.
HobartJKalkersNBarkhofF. Outcome measures for multiple sclerosis clinical trials: Relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Mult Scler2004; 10: 41–46.
5.
HobartJFreemanJThompsonA.Kurtzke scales revisited: the application of psychometric methods to clinical institution. Brain2000; 123: 1027–1040.
6.
NoseworthyJHVandervoortMKWongCJ. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology1990; 40: 971–975.
7.
Meyer-MoockSFengYSMaeurerM. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol2014; 14: 58.
8.
Aboulenein-DjamshidianFKrššákMSerbecicN. CROP – The Clinico-Radiologico-Ophthalmological paradox in multiple sclerosis: Are patterns of retinal and MRI changes heterogeneous and thus not predictable?PLoS ONE2015; 10: e0142272
9.
GassARoccaMAAgostaF. MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis. Lancet Neurol2015; 14: 443–454.
10.
RoviraAWattjesMPTintoréM. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol2015; 11: 471–482.
11.
WattjesMPRoviraÀMillerD.; MAGNIMS Study Group. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients. Nat Rev Neurol2015; 11: 597–606.
RoverCNicholasRStraubeS. Changing EDSS progression in placebo cohorts in relapsing MS: A systematic review and meta-regression. PLoS ONE2015; 10: e0137052
14.
BergamaschiRMontomoliCMallucciG. BREMSO: a simple score to predict early the natural course of multiple sclerosis. Eur J Neurol2015; 22: 981–989.
15.
BergamaschiRQuagliniSTrojanoM. Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score. J Neurol Neurosurg Psychiatry2007; 78: 757–759.
